Reference health

Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene

https://doi.org/10.3390/ph15091043
CiteStamped reference-health badge
63/63 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 63 checked references that resolve
resolves10.1093/femsre/fux013
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
resolves10.3390/ph14080756
Investigation of the Antibacterial Activity and Efflux Pump Inhibitory Effect of Cycas thouarsii R.Br. Extract against Klebsiella pneumoniae Clinical Isolates
resolves10.1002/ejlt.201700330
HPLC‐DAD, ESI–MS/MS, and NMR of Lycopene Isolated From <i>P. guajava</i> L. and Its Biotechnological Applications
resolves10.1007/s11418-010-0443-4
Content variations of the tomato saponin esculeoside A in various processed tomatoes
resolves10.1248/cpb.57.747
A New Spirostanol Glycoside from Fruits of Solanum indicum L.
resolves10.1155/2021/2713511
Lycopene: Food Sources, Biological Activities, and Human Health Benefits
resolves10.1080/10717544.2019.1689312
Oral delivery of lycopene-loaded microemulsion for brain-targeting: preparation, characterization, pharmacokinetic evaluation and tissue distribution
resolves10.1016/j.apsb.2018.06.005
Adapting liposomes for oral drug delivery
resolves10.3390/coatings10020114
Eudragit S100 Entrapped Liposome for Curcumin Delivery: Anti-Oxidative Effect in Caco-2 Cells
resolves10.1016/S0264-410X(00)00537-5
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)
resolves10.1016/j.jddst.2020.101634
Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment
resolves10.2147/IJN.S213613
&lt;p&gt;Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment&lt;/p&gt;
resolves10.3389/fphar.2018.01283
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
resolves10.1016/j.apsb.2011.09.002
Nonionic surfactant vesicular systems for effective drug delivery—an overview
resolves10.1016/j.jconrel.2019.02.002
Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments
resolves10.3390/nano10122472
Novel Surface-Modified Bilosomes as Functional and Biocompatible Nanocarriers of Hybrid Compounds
resolves10.2174/1381612823666170124111142
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides
resolves10.1016/j.bbrc.2015.09.122
Isolation and characterization of (15 Z )-lycopene thermally generated from a natural source
resolves10.1016/j.biopha.2017.11.116
Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity
resolves10.1155/2017/1478625
Lycopene Inhibits Propagation of Chlamydia Infection
resolves10.3389/fcimb.2019.00255
The Interaction of Klebsiella pneumoniae With Lipid Rafts-Associated Cholesterol Increases Macrophage-Mediated Phagocytosis Due to Down Regulation of the Capsule Polysaccharide
resolves10.3389/fmicb.2018.03198
High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit
resolves10.1093/jac/dks396
Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340)
resolves10.1038/srep38929
Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals
resolves10.1080/08982100500528842
Reducing Liposome Size with Ultrasound: Bimodal Size Distributions
resolves10.1002/ddr.20394
Liposomes for enhanced cytotoxic activity of bleomycin
resolves10.3390/pharmaceutics11020055
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
resolves10.3109/1061186X.2012.747528
Characterization and optimization of bilosomes for oral vaccine delivery
resolves10.2147/IJN.S278688
&lt;p&gt;Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation&lt;/p&gt;
resolves10.1016/j.ijpharm.2016.10.006
Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment
resolves10.2147/IJN.S150196
Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
resolves10.1016/j.ijpharm.2004.11.037
Drug interaction and location in liposomes: correlation with polar surface areas
resolves10.1007/s13197-017-2937-5
Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification
resolves10.15171/apb.2016.032
Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid Nanoparticles
resolves10.1155/2018/2627917
The Encapsulation of Lycopene in Nanoliposomes Enhances Its Protective Potential in Methotrexate‐Induced Kidney Injury Model
resolves10.2147/IJN.S268846
&lt;p&gt;In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug&lt;/p&gt;
resolves10.2147/DDDT.S113775
Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate
resolves10.3389/fmicb.2018.01639
Antimicrobial Properties and Mechanism of Action of Some Plant Extracts Against Food Pathogens and Spoilage Microorganisms
resolves10.1016/j.lwt.2014.05.036
Bioactivity and morphological changes of bacterial cells after exposure to 3-(p-chlorophenyl)thio citronellal
resolves10.1517/17425247.2014.942639
Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance:<i>in vitro</i>and<i>in vivo</i>evaluation
resolves10.1016/j.biotechadv.2017.03.012
Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application
resolves10.1016/j.colsurfb.2020.111389
Phytochemical delivery through nanocarriers: a review
resolves10.1080/08982104.2017.1343835
Niosomes for oral delivery of nateglinide:<i>in situ–in vivo</i>correlation
resolves10.3389/fmicb.2021.618922
Antibiofilm Activity of Small-Molecule ZY-214-4 Against Staphylococcus aureus
resolves10.1093/nar/gky427
SWISS-MODEL: homology modelling of protein structures and complexes
resolves10.1038/s41586-022-04555-x
Structural basis of lipopolysaccharide maturation by the O-antigen ligase
resolves10.1073/pnas.1610746113
Structure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanism
resolves10.1002/jcc.21334
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
resolves10.1001/jama.2020.8711
Planning for a COVID-19 Vaccination Program
resolves10.1007/s10096-020-03882-z
Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
resolves10.1016/j.jddst.2017.08.003
Peceosomes for oral delivery of glibenclamide: In vitro in situ correlation
resolves10.1016/j.ijpharm.2015.03.020
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study
resolves10.1016/j.ejps.2018.01.044
Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example
resolves10.1111/j.2042-7158.1975.tb09378.x
The concept of dissolution efficiency
resolves10.1002/jps.2600521210
Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
resolves10.1016/S0928-0987(01)00095-1
Modeling and comparison of dissolution profiles
resolves10.3390/ph15020178
Wound-Healing Potential of Rhoifolin-Rich Fraction Isolated from Sanguisorba officinalis Roots Supported by Enhancing Re-Epithelization, Angiogenesis, Anti-Inflammatory, and Antimicrobial Effects
resolves10.1111/j.1469-0691.2011.03570.x
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
resolves10.3390/ph15020194
In Vivo and In Vitro Antimicrobial Activity of Biogenic Silver Nanoparticles against Staphylococcus aureus Clinical Isolates
resolves10.1038/s41598-021-03953-x
Histological assessment, anti-quorum sensing, and anti-biofilm activities of Dioon spinulosum extract: in vitro and in vivo approach
resolves10.1101/603233
Intraperitoneal treatment with antimicrobial peptide rescues mice from a pulmonary <i>Francisella</i> infection
resolves10.1080/21691401.2022.2056191
Antibacterial activity of nano zinc oxide green-synthesised from <i>Gardenia thailandica</i> triveng. Leaves against <i>Pseudomonas aeruginosa</i> clinical isolates: in vitro and in vivo study
resolves10.3390/antibiotics10121444
Antibacterial, Immunomodulatory, and Lung Protective Effects of Boswelliadalzielii Oleoresin Ethanol Extract in Pulmonary Diseases: In Vitro and In Vivo Studies
The 5 references without a DOI — listed, not checked
no DOI — not checkedBile salts-containing vesicles: Promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines
no DOI — not checkedSurveillance of Klebsiella pneumoniae and antibiotic resistance a retrospective and comparative study through a period in Nepal
no DOI — not checkedEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
no DOI — not checkedCLSI (2020). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute. [30th ed.]. Supplement M100.
no DOI — not checkedAlert, O. (2005). Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3390/ph15091043"><img src="https://citestamp.com/citestamped/10.3390/ph15091043/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3390/ph15091043/badge.svg)](https://citestamp.com/citestamped/10.3390/ph15091043)